Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
With an ovarian KRAS combo ready for review, Verastem’s CEO is poised for the transition
Pharma Voice
Thu, 04/4/24 - 11:18 am
Verastem Oncology
Pharma CEOs
ovarian cancer
Daniel Paterson
Daiichi Sankyo and Merck dose first subject in ovarian cancer trial
Clinical Trials Arena
Thu, 04/4/24 - 10:53 am
Daiichi Sankyo
Merck
ovarian cancer
clinical trials
raludotatug deruxtecan
R-DXd
J&J can contest evidence linking its talc to cancer, US judge rules
Reuters
Thu, 03/28/24 - 11:14 am
JNJ
legal
talc
ovarian cancer
FDA grants full approval to AbbVie's ovarian cancer therapy
Reuters
Sun, 03/24/24 - 10:25 pm
AbbVie
ovarian cancer
Elahere
PhotonPharma receives FDA clearance for ovarian cancer vaccine trial
Clinical Trials Arena
Wed, 03/6/24 - 11:42 am
Photon Pharma
FDA
clinical trials
Innocell
vaccines
ovarian cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Amid CEO turmoil, Allarity loses rights to Novartis cancer drug over missed payments
Fierce Biotech
Fri, 02/2/24 - 11:57 am
Allarity Therapeutics
Novartis
kidney cancer
ovarian cancer
dovitinib
After GSK and Novartis handoffs, Laekna's drug fails ovarian cancer trial
Fierce Biotech
Mon, 01/29/24 - 10:27 pm
Laekna
afuresertib
clinical trials
ovarian cancer
GSK
Novartis
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
AbbVie
M&A
antibody-drug conjugate
Immunogen
Elahere
ovarian cancer
FDA grants IND clearance for ovarian cancer trial of Oncoinvent
Clinical Trials Arena
Wed, 11/1/23 - 10:12 am
Oncoinvent
FDA
Radspherin
ovarian cancer
Mendus shows early comparability data for its universal cancer vaccine
Clinical Trials Arena
Thu, 09/21/23 - 10:39 am
Mendus
vididencel
AML
ovarian cancer
vaccines
Novocure’s tumor-treating electric fields fall short in ovarian cancer trial
Clinical Trials Arena
Tue, 08/29/23 - 11:11 am
Novocure
ovarian cancer
tumor treating fields
Cyteir finally calls it quits after months of cost cutting
Fierce Biotech
Mon, 07/3/23 - 10:41 am
Cyteir Therapeutics
ovarian cancer
dissolution
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
Fri, 06/9/23 - 10:15 am
AstraZeneca
Merck
Lynparza
NICE
UK
ovarian cancer
fallopian tube cancer
ASCO 2023: Precigen reports positive early data for CAR-T therapy
BioSpace
Tue, 06/6/23 - 11:12 am
ASCO 2023
Precigen
CAR-T
PRGN-3005
ovarian cancer
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
Sun, 06/4/23 - 04:24 pm
ASCO 2023
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
Clinical Trials Arena
Wed, 05/17/23 - 10:50 pm
Immunogen
Elahere
clinical trials
platinum-resistant ovarian cancer
ovarian cancer
ImmunoGen reports positive top-line data from ovarian cancer therapy trial
Clinical Trials Arena
Thu, 05/4/23 - 09:17 am
Immunogen
clinical trial
ovarian cancer
platinum-resistant ovarian cancer
Elahere
Trailing AstraZeneca and Merck, Junshi reports phase 3 ovarian cancer success for Lynparza rival
Fierce Biotech
Wed, 04/12/23 - 11:39 am
Junshi Biosciences
PARP inhibitors
ovarian cancer
Merck
AstraZeneca
Lynparza
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »